Literature DB >> 16547760

Protein co-expression with axonal injury in multiple sclerosis plaques.

Maria Diaz-Sanchez1, Kelly Williams, Gabriele C DeLuca, Margaret M Esiri.   

Abstract

Damage to axons in acute multiple sclerosis (MS) lesions is now well established but the mechanisms of this damage remain obscure. Here we have applied a panel of antibodies that identify cell populations and proteins contained in them with a view to detecting those cells and proteins that are localised particularly closely to damaged axons in acute, sub-acute and border-active MS plaques. Results are expressed semi-quantitatively and graphs produced that show that many of the markers show enhanced expression at sites of axon damage. However, the sharpest increase in expression in relation to axon damage was seen for Calpain I (micro-calpain), inducible nitric oxide synthase and MMP-2, suggesting that these proteins may form part of a group of proteins responsible for the initiation of myelin and/or axon damage seen in MS lesions.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16547760     DOI: 10.1007/s00401-006-0045-0

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  29 in total

1.  Cleavage of myelin associated glycoprotein by matrix metalloproteinases.

Authors:  Elizabeth Milward; Kee Jun Kim; Arek Szklarczyk; Thien Nguyen; Giorgia Melli; Mamatha Nayak; Deepa Deshpande; Chantel Fitzsimmons; Ahmet Hoke; Douglas Kerr; John W Griffin; Peter A Calabresi; Katherine Conant
Journal:  J Neuroimmunol       Date:  2007-12-11       Impact factor: 3.478

Review 2.  A molecular trio in relapse and remission in multiple sclerosis.

Authors:  Lawrence Steinman
Journal:  Nat Rev Immunol       Date:  2009-06       Impact factor: 53.106

Review 3.  Mechanisms of neurodegeneration shared between multiple sclerosis and Alzheimer's disease.

Authors:  Hans Lassmann
Journal:  J Neural Transm (Vienna)       Date:  2011-03-05       Impact factor: 3.575

4.  Microglial Hv1 proton channel promotes cuprizone-induced demyelination through oxidative damage.

Authors:  Junli Liu; Daishi Tian; Madhuvika Murugan; Ukpong B Eyo; Cheryl F Dreyfus; Wei Wang; Long-Jun Wu
Journal:  J Neurochem       Date:  2015-08-11       Impact factor: 5.372

5.  Calpeptin attenuated inflammation, cell death, and axonal damage in animal model of multiple sclerosis.

Authors:  M Kelly Guyton; Arabinda Das; Supriti Samantaray; Gerald C Wallace; Jonathan T Butler; Swapan K Ray; Naren L Banik
Journal:  J Neurosci Res       Date:  2010-08-15       Impact factor: 4.164

6.  Original Research: The expression of MMP2 and MMP9 in the hippocampus and cerebral cortex of newborn mice under maternal lead exposure.

Authors:  Ning Li; Xing Li; Li Li; Pingan Zhang; Mingwu Qiao; Qiuyan Zhao; Lianjun Song; Zengli Yu
Journal:  Exp Biol Med (Maywood)       Date:  2016-05-02

7.  Effects of a novel orally administered calpain inhibitor SNJ-1945 on immunomodulation and neurodegeneration in a murine model of multiple sclerosis.

Authors:  Nicole Trager; Amena Smith; Gerald Wallace Iv; Mitsuyoshi Azuma; Jun Inoue; Craig Beeson; Azizul Haque; Naren L Banik
Journal:  J Neurochem       Date:  2014-02-12       Impact factor: 5.372

8.  Increased calpain correlates with Th1 cytokine profile in PBMCs from MS patients.

Authors:  Sarah A Imam; Mary K Guyton; Azizul Haque; Arthur Vandenbark; William R Tyor; Swapan K Ray; Naren L Banik
Journal:  J Neuroimmunol       Date:  2007-09-04       Impact factor: 3.478

9.  Inhibition of calpain attenuates encephalitogenicity of MBP-specific T cells.

Authors:  Mary K Guyton; Saurav Brahmachari; Arabinda Das; Supriti Samantaray; Jun Inoue; Mitsuyoshi Azuma; Swapan K Ray; Naren L Banik
Journal:  J Neurochem       Date:  2009-07-17       Impact factor: 5.372

Review 10.  Calpain-mediated signaling mechanisms in neuronal injury and neurodegeneration.

Authors:  P S Vosler; C S Brennan; J Chen
Journal:  Mol Neurobiol       Date:  2008-08-07       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.